M&A due diligence · Clinical care providers
M&A Privacy & Security Due Diligence for Pharmacies
This service reviews the privacy and security exposure of a pharmacy you are buying, selling or moving to a new banner, so Rx-file custody, retention duties and legacy claims data are priced into the deal rather than discovered after closing. Independent-pharmacy transactions and banner affiliation changes each raise the same core question: who is accountable for the store's PHI history once the deal closes.
Reviewed by the Privacy Horizon team · Last reviewed
What you're protecting
What due diligence has to trace in a pharmacy deal
A pharmacy transaction moves more than fixtures and inventory; it moves a decade or more of PHI custody with obligations that survive the sale.
Rx-file custody and completeness
Confirming that the prescription record set being transferred is complete, properly retained, and accompanied by clear documentation of custody history.
Legacy claims and payer data
Historical ODB and private-plan claims data carries its own retention expectations and needs to be accounted for separately from the current Rx file.
Outstanding breach or discipline exposure
Reviewing whether any unresolved IPC, College or other regulator matters exist that would transfer risk to the buyer along with the store.
PMS and system transition risk
Assessing whether the target's pharmacy-management system can transfer cleanly to the buyer's environment or a new banner's platform without breaking the retention chain.
Regulatory map
The obligations a pharmacy deal has to satisfy
Custodian and retention duties do not pause for a transaction, and due diligence has to confirm the deal structure actually accounts for them.
Custodian status surviving ownership change
PHIPA's custodian obligations attach to the pharmacy's operation, not a specific owner, so the buyer inherits notice, safeguard and reporting duties on day one.
The ten-year retention duty through a sale
OCP's expectation that prescription records be kept a minimum of ten years does not reset at closing, and diligence needs to confirm the buyer or seller has a plan for that duty.
Designated Manager continuity
A change in ownership or banner often means a change in Designated Manager, and diligence should confirm PHI accountability transfers cleanly rather than falling into a gap during transition.
Provincial variation for multi-region deals
Alberta's HIA, BC PIPA and Quebec's Law 25 each attach their own custodian or accountability role to a pharmacy, which a cross-provincial acquisition needs to reconcile deal by deal.
What goes wrong
What gets missed without a pharmacy-specific review
A generic due-diligence checklist built for a typical small business misses the risks specific to a dispensing operation.
Incomplete or scattered Rx files
A store that changed PMS platforms years ago may have historical records in a format the buyer's system cannot easily absorb, threatening the completeness the retention duty requires.
An unresolved snooping or disclosure matter
A past lookup incident still working through College discipline can surface as a liability for the new owner if it was not disclosed and priced into the deal.
Legacy vendor and central-fill obligations
Existing contracts with central-fill operators or delivery-app vendors may carry data-handling terms that bind the buyer even though they were negotiated by the seller.
A banner-change data migration gap
Moving from one banner's PMS to another's can lose historical narcotics reconciliation or claims data if the migration plan does not explicitly preserve it.
Our m&a due diligence for pharmacies
What the due diligence engagement covers
The review is scoped to the deal, whether you are the buyer, the seller, or the pharmacy changing banner affiliation.
Rx-file and retention review
Assessment of the completeness and retention status of the prescription record set being transferred, with specific attention to the ten-year duty.
Regulatory and discipline history check
Review for any known or pending IPC, College or provincial-regulator matters that would carry risk into the new ownership structure.
PMS and system transition assessment
Evaluation of whether the target's current system can transfer or migrate cleanly, and what data-mapping work a banner change would require.
Vendor and contract review
Review of central-fill, delivery-app and other vendor agreements for terms that bind the buyer or that need renegotiation at closing.
Post-close integration plan
Practical guidance for aligning the acquired store's privacy program with the buyer's existing policies, or standing up a compliant program where the buyer is new to pharmacy ownership.
How the engagement runs
How the review runs around your deal timeline
Step 1
Scope the transaction
We confirm deal structure, target province or provinces, and whether the store is changing PMS or banner affiliation as part of the transaction.
Step 2
Review records and documentation
We assess Rx-file completeness, retention documentation, past regulatory matters and vendor contracts against what the deal requires to close cleanly.
Step 3
Report findings for negotiation
Findings are delivered in time to inform price, representations and warranties, or closing conditions, not as a post-close surprise.
Step 4
Support post-close integration
We help the new owner or Designated Manager stand up or align the privacy program once the deal closes, including any needed retention or migration work.
What it costs
What drives due diligence cost for a pharmacy deal
Cost depends on the size and complexity of the store or banner being acquired, how many provinces are involved, whether a PMS or banner change is part of the deal, and how much documentation the seller can produce readily. A single-store acquisition with clean records is a narrower engagement than a multi-store deal involving a banner-platform migration.
Buyers and sellers both benefit from commissioning this review early enough to inform deal terms rather than closing conditions. A short scoping call, ideally before a purchase agreement is drafted, is enough to price the work.
Pharmacies: M&A due diligence questions, answered
At minimum, confirm the Rx file being transferred is complete and properly retained, check for any unresolved IPC or College matters tied to the store, review the current PMS vendor's terms for data portability, and confirm the outgoing Designated Manager's accountability transfers cleanly to whoever will hold that role after closing. These checks belong in due diligence, not in the weeks after you already own the store.
Rx-file custody generally transfers with the pharmacy's operation, since the records exist to support ongoing patient care and the ten-year retention duty attaches to the business rather than a specific owner. The transaction should document this transfer explicitly, including how records are migrated if the buyer uses a different PMS, so there is no ambiguity about who holds the complete file after closing.
Historical ODB and private-plan claims data typically transfers along with the Rx file, since it documents past dispensing and payment activity tied to the same patients. Diligence should confirm this data is accessible in a usable format post-close, since a buyer who cannot produce historical claims records if questioned by a payer or regulator inherits a documentation gap they did not create.
This depends on deal structure and needs to be addressed explicitly in the purchase agreement, since custodian accountability for information now held by the buyer does not automatically resolve who bears responsibility for a pre-close incident. Diligence surfaces any known incidents so the parties can negotiate representations, warranties or indemnities that reflect the actual risk rather than leaving it ambiguous.
As early as practical, ideally before final terms are set, since findings from a privacy and security review can affect price or the closing conditions themselves. Starting the review only after a purchase agreement is signed limits what can still be negotiated and turns findings into problems to manage rather than terms to price.
More for pharmacies
Other services for this niche
About this service
What's Protecting Your Business from the Next Threat?
Don't wait for a breach to expose your vulnerabilities. Let Privacy Horizon secure your data, ensure compliance, and build lasting trust.